Skip to main content


Browse the latest news, expert commentary, and educational content on COVID-19.


20-10-2021 | COVID-19 | News

Data favor TNF inhibitor monotherapy for IMIDs during COVID-19 pandemic

TNF inhibitor monotherapy is associated with a lower risk for COVID-19-related hospitalization or death than other common immunomodulatory treatments given to people with immune-mediated inflammatory diseases, research suggests.

16-09-2021 | COVID-19 | News

Low rates of breakthrough SARS-CoV-2 infection after vaccination in people with RMDs

Preliminary findings from two studies point to low overall rates of breakthrough COVID-19 following vaccination in people with rheumatic and musculoskeletal diseases.

06-09-2021 | COVID-19 | News

Glucocorticoids, B-cell depleting therapies may dampen immune response to COVID-19 vaccines

Most people with inflammatory diseases treated with immunomodulatory therapies mount an antibody response to mRNA vaccines against SARS-CoV-2, but the response may be blunted in those taking glucocorticoids or B cell-depleting therapies, shows the COVaRiPAD study.

COVID-19 vaccination in patients with rheumatic diseases

Get answers to key questions with recommendations from professional organizations

COVID-19 in rheumatic disease patients

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

Repurposing rheumatology drugs for COVID-19

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

COVID-19 guidance for rheumatologists

Keep up with podcasts on this topic, available on

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Image Credits